119 related articles for article (PubMed ID: 3343838)
1. Regression analyses of prognostic factors in colorectal cancer.
Hannisdal E; Thorsen G
J Surg Oncol; 1988 Feb; 37(2):109-12. PubMed ID: 3343838
[TBL] [Abstract][Full Text] [Related]
2. Clinico-pathological prognostic factors of large bowel cancer in Singapore: a multivariate analysis.
Goh HS; Goh CR; Rauff A; Foong WC
Ann Acad Med Singap; 1987 Jul; 16(3):437-40. PubMed ID: 3435010
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
4. Jass' classification revisited.
Deans GT; Heatley M; Anderson N; Patterson CC; Rowlands BJ; Parks TG; Spence RA
J Am Coll Surg; 1994 Jul; 179(1):11-7. PubMed ID: 8019715
[TBL] [Abstract][Full Text] [Related]
5. A regression analysis of prognostic factors after resection of Dukes' B and C carcinoma of the rectum and rectosigmoid. Does post-operative radiotherapy change the prognosis?
Bentzen SM; Balslev I; Pedersen M; Teglbjaerg PS; Hanberg-Soerensen F; Bone J; Jacobsen NO; Overgaard J; Sell A; Bertelsen K
Br J Cancer; 1988 Aug; 58(2):195-201. PubMed ID: 3166910
[TBL] [Abstract][Full Text] [Related]
6. Preoperative lymphocyte counts in peripheral blood in patients with colorectal neoplasms: a correlation with tumor type, Dukes' classification, site of primary tumor, and five-year survival rate in 1,000 patients.
Thynne GS; Moertel CG; Silvers A
Dis Colon Rectum; 1979; 22(4):221-2. PubMed ID: 467174
[No Abstract] [Full Text] [Related]
7. Independent prognostic value of ploidy in colorectal cancer. A prospective study using image cytometry.
Albe X; Vassilakos P; Helfer-Guarnori K; Givel JC; de Quay N; Suardet L; Eliason JF; Odartchenko N
Cancer; 1990 Sep; 66(6):1168-75. PubMed ID: 2400968
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of lymphatic permeation in Dukes' B colorectal cancer.
Agrez MV; Spagnolo D; Harvey J; House AK; O'Connell D
Aust N Z J Surg; 1988 Jan; 58(1):39-42. PubMed ID: 3415584
[TBL] [Abstract][Full Text] [Related]
9. Blood transfusions and survival after colectomy for colorectal cancer.
Corman J; Arnoux R; Péloquin A; St-Louis G; Smeesters C; Giroux L
Can J Surg; 1986 Sep; 29(5):325-9. PubMed ID: 3756652
[TBL] [Abstract][Full Text] [Related]
10. The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer.
Moertel CG; O'Fallon JR; Go VL; O'Connell MJ; Thynne GS
Cancer; 1986 Aug; 58(3):603-10. PubMed ID: 3731019
[TBL] [Abstract][Full Text] [Related]
11. Survival in patients with large-bowel cancer. A population-based investigation from the Melbourne Colorectal Cancer Study.
Kune GA; Kune S; Field B; White R; Brough W; Schellenberger R; Watson LF
Dis Colon Rectum; 1990 Nov; 33(11):938-46. PubMed ID: 2226081
[TBL] [Abstract][Full Text] [Related]
12. Serum YKL-40 and colorectal cancer.
Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
Br J Cancer; 1999 Mar; 79(9-10):1494-9. PubMed ID: 10188896
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancer. Dukes' stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern.
Scott NA; Wieand HS; Moertel CG; Cha SS; Beart RW; Lieber MM
Arch Surg; 1987 Dec; 122(12):1375-9. PubMed ID: 3689111
[TBL] [Abstract][Full Text] [Related]
14. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
[TBL] [Abstract][Full Text] [Related]
15. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of peripheral lymphocyte counts and carcinoembryonic antigens in colorectal carcinoma.
Kim US; Papatestas AE; Aufses AH
J Surg Oncol; 1976; 8(3):257-62. PubMed ID: 933547
[TBL] [Abstract][Full Text] [Related]
17. Completely obstructive colorectal cancer.
Kaufman Z; Eiltch E; Dinbar A
J Surg Oncol; 1989 Aug; 41(4):230-5. PubMed ID: 2755139
[TBL] [Abstract][Full Text] [Related]
18. Survival for colon and rectal cancer in a population-based cancer registry.
Roncucci L; Fante R; Losi L; Di Gregorio C; Micheli A; Benatti P; Madenis N; Ganazzi D; Cassinadri MT; Lauriola P; Ponz de Leon M
Eur J Cancer; 1996 Feb; 32A(2):295-302. PubMed ID: 8664045
[TBL] [Abstract][Full Text] [Related]
19. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: independent prognostic role of p53 and bcl-2.
Buglioni S; D'Agnano I; Cosimelli M; Vasselli S; D'Angelo C; Tedesco M; Zupi G; Mottolese M
Int J Cancer; 1999 Dec; 84(6):545-52. PubMed ID: 10567896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
